Solifenacin contains solifenacin and is used to treat symptoms of overactive bladder (OAB), including urinary urgency, increased frequency of urination, and urge incontinence. An overactive bladder occurs when the bladder muscle contracts involuntarily, leading to a sudden and difficult-to-control urge to pass urine. Solifenacin works by relaxing the bladder muscles, helping improve bladder control and reduce accidental leakage. It may be used alone or alongside behavioural therapies such as bladder training and pelvic floor exercises.

Solifenacin contains solifenacin, an antimuscarinic (anticholinergic) medication prescribed for managing overactive bladder symptoms. It works by selectively blocking muscarinic M3 receptors in the bladder wall, which are responsible for detrusor muscle contraction.

By inhibiting these receptors, solifenacin reduces involuntary bladder contractions and increases bladder storage capacity. This helps decrease urgency, frequency, nocturia (nighttime urination), and episodes of urge urinary incontinence.

The medicine begins acting within hours of ingestion, but noticeable improvement may take several days to weeks of consistent daily use. Maximum benefit is typically observed after 2 - 4 weeks.

Solifenacin is metabolised in the liver, primarily through the CYP3A4 enzyme pathway, and eliminated via urine and faeces. Dose adjustments may be required in patients with severe renal or hepatic impairment. When taken as prescribed, Solifenacin is an effective long-term option for improving bladder control and enhancing quality of life.

Overactive Bladder (OAB)

Reduces urinary urgency, frequency, and urge incontinence.

Urge Incontinence

Helps control involuntary urine leakage caused by sudden bladder contractions.

Nocturia

Decreases nighttime urination episodes linked to bladder overactivity.

Neurogenic Bladder (Off-label)

May be used in select cases under specialist supervision.

Improves Bladder Control

Reduces sudden urgency and leakage episodes.

Increases Bladder Capacity

Allows the bladder to hold more urine before signalling the need to void

Reduces Urinary Frequency

Decreases both daytime and nighttime urination.

Enhances Quality of Life

Improves confidence, sleep quality, and daily comfort.

Once-Daily Dosing

Convenient single daily dose improves adherence.

Targeted Action

Selectively blocks bladder M3 receptors, aiming to minimise systemic side effects.

When taken as prescribed, Solifenacin is generally well tolerated. Most side effects are related to its anticholinergic mechanism and are mild to moderate. They often improve as the body adjusts during the first few weeks of therapy.

Common Side Effects

• Dry Mouth: The most frequently reported side effect due to reduced saliva production. Maintaining hydration and using sugar-free lozenges may provide relief.

• Constipation: Occurs because of decreased intestinal motility. Increasing fibre intake, fluid consumption, and physical activity can help manage symptoms.

• Blurred Vision: Temporary difficulty focusing, particularly when reading or using screens. Patients should avoid driving if their vision is affected.

• Indigestion or Nausea: Mild gastrointestinal discomfort may occur during early treatment and often improves with continued use.

Uncommon Side Effects

• Urinary Retention: Difficulty emptying the bladder completely. Individuals with prostate enlargement or bladder outlet obstruction are at higher risk.

• Drowsiness: Mild sedation or fatigue may occur, especially at higher doses.

• Dry Eyes: Reduced tear production may cause discomfort, particularly for contact lens users.

Serious Side Effects (Require Immediate Medical Attention)

• Severe Allergic Reaction: Rash, itching, facial swelling, or breathing difficulty.

• Severe Urinary Retention: Complete inability to urinate, requiring urgent evaluation.

• Confusion or Hallucinations: More common in elderly patients due to central anticholinergic effects.

• Irregular Heart Rhythm (QT Prolongation): Palpitations, fainting, or dizziness may indicate cardiac rhythm disturbances.

Solifenacin should be taken exactly as prescribed. The usual starting dose is one tablet once daily at the same time each day. Based on response and tolerability, the dose may be increased once daily under medical supervision.

Swallow the tablet whole with water. It can be taken with or without food. Do not crush or chew the tablet.

Solifenacin is a competitive antagonist of muscarinic acetylcholine receptors, particularly the M3 subtype in the bladder’s detrusor muscle.

Normally, acetylcholine binds to M3 receptors and triggers bladder muscle contraction. In an overactive bladder, these contractions occur involuntarily and too frequently. By blocking these receptors, solifenacin reduces involuntary contractions, increases bladder capacity, and delays the urge to urinate.

This selective M3 receptor blockade provides effective symptom control while aiming to limit widespread anticholinergic effects.

• Take It Consistently: Take the medicine at the same time each day to maintain steady blood levels and optimal bladder control.

• Allow Time for Effect: Full benefits may take 2 - 4 weeks. Continue therapy as prescribed, even if improvement is gradual.

• Monitor for Urinary Retention: Seek medical attention if you experience difficulty urinating or incomplete bladder emptying.

• Manage Dry Mouth and Constipation: Maintain oral hygiene, adequate hydration, and a fibre-rich diet to reduce common side effects.

• Elderly Monitoring: Older adults should be monitored for confusion, excessive drowsiness, or cognitive changes.

• Avoid Overheating: Reduced sweating may increase heat sensitivity. Stay hydrated and avoid excessive heat exposure.

• Inform Your Doctor About All Medications: Especially mention antifungals, antibiotics, heart rhythm medicines, or other anticholinergic drugs.

• Combine with Behavioural Therapy: Pelvic floor exercises and bladder training significantly enhance long-term symptom control.

• Do Not Self-Adjust Dose: Any dose change should be supervised by a healthcare professional.

While Solifenacin can be taken with or without food, certain dietary factors may influence tolerability and symptom control.

1. Alcohol (Moderate): May increase dizziness and sedation. Limit consumption.
2. Caffeine (Moderate): May stimulate bladder activity and worsen urgency symptoms.
3. Grapefruit (Moderate): May increase drug levels by inhibiting CYP3A4, potentially raising side-effect risk.
4. Low-Fibre Diet (Moderate): May worsen constipation; adequate fibre intake is recommended.
5. Excess Fluid Intake (Moderate): Large fluid volumes may counteract treatment benefits in OAB management.

Solifenacin can interact with medications affecting liver enzymes, heart rhythm, or possessing anticholinergic properties.

1. Strong CYP3A4 Inhibitors (High): Ketoconazole, clarithromycin, and ritonavir may increase solifenacin levels.
2. Other Anticholinergic Drugs (High): Increased risk of dry mouth, constipation, blurred vision, and confusion.
3. QT-Prolonging Medicines (Moderate-High): Increased risk of cardiac arrhythmias.
4. Cholinergic Agents (Moderate): May reduce therapeutic effectiveness.
5. Metoclopramide and Prokinetic Drugs (Moderate): Reduced gastrointestinal motility effects.

Solifenacin should be used cautiously in patients with certain medical conditions.

1. Urinary Retention (High): May worsen bladder emptying difficulties.
2. Gastric Retention (High): Can aggravate slowed gastrointestinal motility.
3. Narrow-Angle Glaucoma (High): May increase intraocular pressure.
4. Severe Liver Disease (High): Reduced metabolism may increase side-effect risk.
5. Severe Kidney Disease (Moderate-High): Drug accumulation may occur; dose adjustment required.
6. Myasthenia Gravis (Moderate): May worsen muscle weakness.
7. Cardiac Arrhythmias (Moderate): QT prolongation risk requires monitoring.

If you miss a dose, take it as soon as you remember on the same day. If it is close to your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take two doses in one day. Regular dosing ensures consistent symptom control.